Time to patient discontinuation of antihypertensive drugs in different classes

American Journal of Health-System Pharmacy

Volumn 57, Issue 1, 2000, Pages 51-54

  Benson, Steven ^a,b   Vance Bryan, Kyle ^a   Raddatz, Janet ^a  

^a Express Scripts   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ANTIHYPERTENSIVE AGENT; ATENOLOL; HYDROCHLOROTHIAZIDE PLUS TRIAMTERENE; LISINOPRIL; LOSARTAN; NIFEDIPINE; QUINAPRIL;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL;

EID: 0033985908     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/57.1.51     Document Type: Article

References (18)

1. American Heart Association 1998 statistical update. Dallas: American Heart Association; 1998:1-29.
2. Kannel WB. Blood pressure as a cardiovascular risk factor. Prevention and treatment. JAMA. 1996; 275:1571-9.
3. National High Blood Pressure Education Program. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1997; 157:2413-46.
4. Maolio TA, Cutler JA, Furberg CD et al. Trends in pharmacologic management of hypertension in the United States. Arch Intern Med. 1995; 155:829-37.
5. Juncos LI. Patient compliance and angiotensin converting enzyme inhibitors in hypertension. J Cardiovasc Pharmacol. 1990; 15(suppl 3):S22-5.
6. Klein LE. Compliance and blood pressure control. Hypertension. 1988; 11(3, part 2): II61-4.
7. Caro JJ. Stepped care for hypertension: are the assumptions valid? J Hypertens Suppl. 1997; 15:S35-9.
8. Rizzo JA, Simons WR. Variations in compliance among hypertensive patients by drug class: implications for health care costs. Clin Ther. 1997; 19:1446-57.
9. Monane M, Bohn RL, Gurwitz JH et al. The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: results from a population-based study in the elderly. Am J Hypertens. 1997; 10(7, part 1): 697-704.
10. Kaplan NM, Gifford RW. Choice of initial therapy for hypertension. JAMA. 1996; 275: 1577-80.
11. Materson BJ, Reda DJ, Cushman WC et al. Single-drug therapy for hypertension in men. N Engl J Med. 1993; 328:914-21.
12. Neaton JD, Grimm RH, Prineas RJ et al. Treatment of Mild Hypertension Study; final results. JAMA. 1993; 270:713-24.
13. Psaty BM, Savage PJ, Tell GS et al. Temporal patterns of antihypertensive medication use among elderly patients. The Cardiovascular Health Study. JAMA. 1993; 270:1837-41.
14. Cauley JA, Cummings SR, Seeley DG et al. Effects of thiazide diuretic therapy on bone mass, fractures and falls. Ann Intern Med. 1993; 118:666-73.
15. Straka RJ, Fish JT, Benson SR et al. Magnitude and nature of noncompliance with treatment using isosorbide dinitrate in patients with ischemic heart disease. J Clin Pharmacol. 1996; 36:587-94.
16. Patel SC, Spaeth GL. Compliance in patients prescribed eyedrops for glaucoma. Ophthalmic Surg. 1995; 26:233-6.
17. Sellwood W, Tarrier N. Demographic factors associated with extreme non-compliance in schizophrenia. Soc Psychiatry Psychiatr Epidemiol. 1994; 29:172-7.
18. Haynes RB, Sackett DL, Gibson ES et al. Improvement of medication compliance in uncontrolled hypertension. Lancet. 1976; 1: 1265-8.